1. Market Research
  2. > Diagnostics Market Trends
  3. > Injectable Drug Delivery to 2022

Injectable Drug Delivery to 2022

  • December 2014
  • -
  • Greystone Research Associates

The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as prefilled syringes and specialized injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved increasingly from practitioner offices and healthcare facilities to patient homes. This report examines the key therapeutic, product, market and regulatory factors for injectable drugs across ten major disease and therapeutic classes, providing essential insight and forecasts into the implications of this evolving landscape.

Highlights
- Analyzes and evaluates the shifting landscape for injectable drug delivery and assesses the market impact of new and emerging injectable drug products by therapeutic indication

- Analyzes syringe and injector device designs, feature/functionality, product branding, competing technologies and market development issues

- Provides detailed descriptions of key injectable drug therapeutic market segments, market demographics, and business strategies

- Forecasts Injectable drug product demand by indication and therapy to 2022

- Profiles leading injection device companies, their product development activities, business strategies, and corporate alliances and affiliations

Table Of Contents

Injectable Drug Delivery to 2022
Summary of Contents
Executive Summary

Injectable Drug Delivery Market Dynamics

The Injectable Drug Ecosystem
Injectable Drug Demand Drivers
Drug Development Factors
Market Factors
Technology Factors
Competitive Landscape
Autoinjectors
Needle-free Injectors
Pen Injectors
Prefilled Syringes
Safety Syringes
Risks and Opportunities

Injectable Drug Device Selection Criteria

Stability and Material Selection Issues
Single vs Multi-Dose Devices
Lyophilized Drugs/Reconstitution
Syringe Safety/Sharps Protection
Needle Configuration Strategies
Disposable Drug Cartridges
Human Engineering/Ergonomics
Branding/Private Labeling

Injectable Drug Delivery - Device Segments

Autoinjectors
Autoinjector-specific Selection Factors
Part Counts and Device Cost
Safety Features
Needle Shielding
Needle Insertion Depth
Failsafe Activation
Dose Inspection/Injection Confirmation
Autoinjector Device Categories
Reusable Autoinjectors
Disposable Autoinjectors
Product Specific Autoinjectors
Drugs and Therapeutic Segments

Needle-free Injectors
Device Categories
End User/Practitioner/Mass Immunization Injectors
Prefilled Disposable Models
Refillable Cartridge Designs
Energy Source

Pen Injectors
Pen Injector Device Categories
Standardized Pen Platforms
Custom Pen Designs
Prefilled Pen Cartridges
Disposable Pens
Dual Chamber Pens
Branded Drug/Pen Injector Product by Therapeutic Segment

Prefilled Syringes
Prefilled Syringe Device Categories
Glass Prefilled Syringes
Prefillable Glass Syringe Manufacturers and Branded Devices
Branded Drug/Prefilled Glass Syringe Products by Therapeutic Segment
Plastic Prefilled Syringes
Branded Prefillable Plastic Syringes
Drugs and Therapeutic Segments
Prefillable Safety Syringes
Prefilled Syringe-specific Selection Factors
PFS Manufacturing Factors
Fill-and-Finish Operations

Safety Syringes
Safety Syringe Device Categories
Prefillable Integrated Safety Syringes
Non-Prefillable Integrated Safety Syringes

Injectable Drug Delivery - Therapeutic Segment Analysis and Forecasts

Anaphylaxis
Anticoagulants
Antivirals
Autoimmune Diseases
Emergency Medicine
Hematopoietics
Hormone Replacement
Metabolic Diseases
Neurology
Reproductive Health
Vaccines

Injectable Drug Therapeutics - Market Factors

Regulatory Factors and Issues
FDA Regulations
Regulating Combination Products
Sharps Legislations
Clinical Trial Factors
Managed Care and Healthcare Economics

Company Profiles

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
A 33-Country Survey of the Infectious Disease Testing Market: Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Instrumentation Review, Emerging Technologies, Opportunities for Suppliers (DataPack)

A 33-Country Survey of the Infectious Disease Testing Market: Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Instrumentation Review, Emerging Technologies, Opportunities for Suppliers (DataPack)

  • $ 54 500
  • Industry report
  • February 2016
  • by Venture Planning Group

This DataPack contains tables from VPGMarketResearch.com new report, "A 33-Country Survey of the Infectious Disease Testing Market: Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, ...

A 33-Country Survey of the Virology and Bacteriology Testing Market: Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation Review, Emerging Technologies, Opportunities for Suppliers (DataPack)

A 33-Country Survey of the Virology and Bacteriology Testing Market: Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation Review, Emerging Technologies, Opportunities for Suppliers (DataPack)

  • $ 54 500
  • Industry report
  • February 2016
  • by Venture Planning Group

This DataPack contains tables from VPGMarketResearch.com new report, "A 33-Country Survey of the Virology and Bacteriology Testing Market: Sales and Volume Forecasts for 100 Microbiology Tests, Supplie ...

A 33-Country Survey of the Automated Microbiology Market: Supplier Shares, Sales and Volume Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

A 33-Country Survey of the Automated Microbiology Market: Supplier Shares, Sales and Volume Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47 500
  • Industry report
  • February 2016
  • by Venture Planning Group

This report is delivered in 10-15 working days This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from ...

Diagnostics Bundle

January 2016 $ 41 225

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.